<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The incidence of Kaposi <z:hpo ids='HP_0100242'>sarcoma</z:hpo>, non-Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, and <z:e sem="disease" ids="C0302592" disease_type="Neoplastic Process" abbrv="">cervical cancer</z:e> has been declining among persons with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>We investigated the association between <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risk and CD4 cell count among such persons </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Data from US <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e> registries were linked to <z:e sem="disease" ids="C0796563" disease_type="Neoplastic Process" abbrv="">local cancer</z:e> registry data </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> incidence per 100,000 person-years was determined for the 4-27 months from the <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e> from January 1, 1990, through December 31, 1995--before highly active antiretroviral therapy (HAART) became available--and from January 1, 1996, through December 31, 2002 </plain></SENT>
<SENT sid="4" pm="."><plain>The relationships between CD4 count at <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e> <z:hpo ids='HP_0003674'>onset</z:hpo> and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> incidence were assessed by proportional hazards models </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Among 325,516 adults with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e>, the incidence of Kaposi <z:hpo ids='HP_0100242'>sarcoma</z:hpo> was lower in 1996-2002 (334.6 cases per 100,000 person-years) than in 1990-1995 (1838.9 cases per 100,000 person-years), and the incidence of non-Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo> followed a similar pattern (i.e., 390.1 cases per 100,000 person-years in 1996-2002 and 1066.2 cases per 100,000 person-years in 1990-1995) </plain></SENT>
<SENT sid="6" pm="."><plain>In 1996-2002, for each decline in CD4 cell count of 50 cells per microliter of blood, increased risks were found for Kaposi <z:hpo ids='HP_0100242'>sarcoma</z:hpo> (hazard ratio [HR] = 1.40, 95% confidence interval [CI] = 1.33 to 1.50), for central <z:mp ids='MP_0008912'>nervous</z:mp> system non-Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo> subtypes (HR = 1.85, 95% CI = 1.58 to 2.16), and for non-central <z:mp ids='MP_0008912'>nervous</z:mp> system diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (HR = 1.12, 95% CI = 1.04 to 1.20) but not for non-central <z:mp ids='MP_0008912'>nervous</z:mp> system Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (HR = 0.93, 95% CI = 0.81 to 1.06) </plain></SENT>
<SENT sid="7" pm="."><plain><z:e sem="disease" ids="C0302592" disease_type="Neoplastic Process" abbrv="">Cervical cancer</z:e> incidence was higher in 1996-2002 (86.5 per 100,000 person-years) than in 1990-1995 (64.2 per 100,000 person-years), although not statistically significantly so (relative risk [RR] = 1.41, 95% CI = 0.81 to 2.46) </plain></SENT>
<SENT sid="8" pm="."><plain>After adjustment for age, race, and sex or mode of HIV exposure, the risks for Kaposi <z:hpo ids='HP_0100242'>sarcoma</z:hpo> (RR = 0.22, 95% CI = 0.20 to 0.24) and for non-Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (RR = 0.40, 95% CI = 0.36 to 0.44) were lower in the period of 1996-2002 than in 1990-1995 </plain></SENT>
<SENT sid="9" pm="."><plain>Similar relationships of these <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> to CD4 count were observed for 1990-1995 </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: Both before and after HAART was available, CD4 count was strongly associated with risks for Kaposi <z:hpo ids='HP_0100242'>sarcoma</z:hpo> and non-Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo> but not for <z:e sem="disease" ids="C0302592" disease_type="Neoplastic Process" abbrv="">cervical cancer</z:e> and Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>The decreasing incidences of most <z:e sem="disease" ids="C0280734" disease_type="Neoplastic Process" abbrv="">AIDS-associated cancers</z:e> in persons with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e> during the 1990s are consistent with improving CD4 counts after HAART introduction in 1996 </plain></SENT>
</text></document>